MENU
GET LISTED
GET LISTED
SHOW ALLPOPULAR CATEGORIES

Compare Freemake Video Converter vs iMovie

SCORES FEATURES PRICING PRICING MODEL INTEGRATIONS

What is better Freemake Video Converter or iMovie? It’s easy to our scoring system to help you get a general idea which Video Editing Software product is more suitable for your company. For overall product quality, Freemake Video Converter earned 8.9 points, while iMovie received 9.4 points. Meanwhile, for user satisfaction, Freemake Video Converter scored 98%, while iMovie scored 82%.

Details about their characteristics, tools, supported platforms, customer service, and more are given below to give you a more correct analysis. Keep in mind to purchase only the features that you need so you don’t waste cash for tools that are unnecessary.

Right now, the best solutions in our Video Editing Software category are: Filmora, Adobe Premiere Pro, Final Cut Pro.

In case you continue having second thoughts about which product will perform best in your case it may be a sound idea to check out each service’s social metrics. Such metrics are usually an indicator of how popular every solution is and how big is its online presence. For example, in case of Facebook Freemake Video Converter has 700557 likes on their official page while iMovie profile is liked by 10933004 users.

Page last modified

Why is FinancesOnline free? Why is FinancesOnline free?

FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.